Liege, Belgium – 3 July 2025 – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has successfully […]
Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, […]
Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, […]
Liege, Belgium – 4 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology-based treatment for degenerative joint […]
Liege, Belgium – 11 December 2024 (07:30 CET) – Allegro NV, a biomedical companydeveloping transformative nanotechnology-based devices for degenerative joint disease, todayannounced […]